SAB Biotherapeutics, Inc. (SABS): SCHEDULE 13G filed May 15, 2026

Form type

SCHEDULE 13G

Filing date

May 15, 2026

Accession number

0001193125-26-225169

Filer

SAB Biotherapeutics, Inc. (CIK 1833214)